Machine Learning Helps Marketers

Machine Learning Helps Marketers

For some, the term machine learning may conjure up images of virtual assistants or automated tools.

Medtronic hires Gregory Zimprich as financial comms director

Medtronic hires Gregory Zimprich as financial comms director

Zimprich joins from Honeywell, where he led global business communications.

Did Congress just kill the Orphan Drug Act?

Did Congress just kill the Orphan Drug Act?

By allowing companies to claim a 50% tax credit for qualified clinical testing expenses, developing drugs for rare diseases became economically feasible for the first time.

Real-world evidence: It's finally having its moment

Real-world evidence: It's finally having its moment

Fueled by system-wide demand and facilitated by AI, the industry's lofty expectations around real-world evidence could soon be fulfilled

Amazon's ability to attract other employers makes its healthcare coalition very formidable, experts say

Amazon's ability to attract other employers makes its healthcare coalition very formidable, experts say

Details are vague, but the e-commerce giant indicated it's serious about getting into healthcare.

Somatix picks Finn Partners as marcomms AOR

Somatix picks Finn Partners as marcomms AOR

Somatix is a digital health platform that tracks movements through smartwatches.

We Save Lives While Our Critics Complain

We Save Lives While Our Critics Complain

In his first press conference as president-elect, Donald Trump insisted pharma was "getting away with murder" due to expensive drug prices.

Goodbye, YouTube. Regulations could prompt microinfluencer migration to other platforms

Goodbye, YouTube. Regulations could prompt microinfluencer migration to other platforms

Some microinfluencers see the latest YouTube guidelines as a "slap in the face."

Google: slow mobile pages will hurt your ranking

Google: slow mobile pages will hurt your ranking

Advertisers have until July to get their mobile pages up to speed.

Five things for pharma marketers to know: Wednesday, January 17, 2018

Five things for pharma marketers to know: Wednesday, January 17, 2018

Celgene reportedly in talks to buy Juno; Novartis' Kymriah receives fast-track reviews in U.S. and Europe; BI's Gilotrif gets expanded approval in lung cancer

No Female Keynotes at CES but Alexa's Voice was Heard Above All Others

No Female Keynotes at CES but Alexa's Voice was Heard Above All Others

The tech that's most likely to survive post-CES hype is voice but brands should rethink their gendered approach.

Can digital tools really change patient behavior?

Can digital tools really change patient behavior?

New research calls into question the behavioral effects of some digital health tools.

Five things for pharma marketers to know: Thursday, January 11, 2018

Five things for pharma marketers to know: Thursday, January 11, 2018

Novartis Oncology taps Pfizer exec as CEO; healthcare jobs become the largest source of U.S. employment; HHS nominee wary about drug-pricing negotiations

Five things for pharma marketers to know: Wednesday, January 10, 2018

Five things for pharma marketers to know: Wednesday, January 10, 2018

Maker of Botox biosimilar Evolus files IPO; pharma execs expect major acquisitions in 2018; J&J and Bayer win Xarelto reversal verdict

No Google, no problem: Pharma partners with China's tech giants

No Google, no problem: Pharma partners with China's tech giants

In the absence of behemoths such as Facebook and Twitter, pharma is partnering with China's tech giants to snare a slice of a more than $100 billion market